MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer

(MRFLA Trial)

Recruiting in Palo Alto (17 mi)

Overseen by FERNANDO J BIANCO, MD

Age: 18+

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Urological Research Network, LLC

No Placebo Group

Trial Summary

What is the purpose of this trial?

This serves as a registration trial. It aims to record short, intermediate, and long-term outcomes of patients treated with targeted laser ablation of biopsy confirmed prostate cancer. Outcomes will be categorized as: 1- Procedure Related, 2- Perioperative - Adverse Events that may occur within 90 days, 3-Oncologic: Recurrence of cancer in treatment area, de-novo tumors, conversion to radical surgery, radiation or cryoablation, emergence of metastasis, 4- Functional: Sexual and Urinary function following treatment

Research Team

FERNANDO J BIANCO, MD

Principal Investigator

UROLOGICAL RESEARCH NETWORK

EUSEBIO LUNA, MD

Principal Investigator

UROLOGICAL RESEARCH NETWORK

Isabel H Lopez, MD

Principal Investigator

UROLOGICAL RESEARCH NETWORK

Eligibility Criteria

Inclusion Criteria

Absence of regional or distant metastatic disease

Multiparametric MRI of the prostate performed either before the biopsy or >10 weeks after prostate biopsy

Treated with Cryotherapy of the prostate

Treatment Details

Interventions

• MRI/Ultrasound Fusion Guided Laser Ablation (Procedure)

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Urological Research Network Miami Lakes, FL

Who Is Running the Clinical Trial?

Urological Research Network, LLC

Lead Sponsor

Trials

5

Patients Recruited

10,200+

References